Market Overview:
The global postpartum depression treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of postpartum depression, rising awareness about postpartum depression, and growing demand for better treatment options for postpartum depression. The global postpartum depression treatment market is segmented on the basis of type into selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), and other antidepressants. The SSRI segment is expected to account for the largest share of the global postpartum depression treatment market in 2018. This segment is projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The SNRI segment is projected to grow at a CAGR of 6% during the same period.
Product Definition:
Postpartum Depression Treatment is the process of helping women who are suffering from depression after giving birth. It is important to get treatment for postpartum depression because it can interfere with a woman's ability to take care of herself and her baby.
Selective Serotonin Reuptake Inhibitors:
Postpartum depression is a type of depression that occurs in women after they give birth to a child. It affects around 15-20% of mothers, usually within 4-6 weeks of the delivery date. The condition may persist for months or years and has been known to affect up to one third of all mothers following childbirth.
SSRI’s are commonly used drugs for the treatment.
Serotonin Norepinephrine Reuptake Inhibitors:
SSNIP (serotonin norepinephrine reuptake inhibitors) market is expected to witness lucrative growth over the forecast period owing to increasing prevalence of depression in pregnant women and need for effective treatment options. According to statistics published by WHO, globally one out of every ten people suffers from depression. In addition, as per data published by CDC; annually around 10% of all new cases diagnosed with mental disorders are related to pregnancy-related depression.
Application Insights:
The others application segment held the largest share of over 50.0% in 2017. The other applications include private practices, primary care clinics and emergency rooms. Postpartum depression is a common condition that affects women, especially after childbirth. As stated by the Centers for Disease Control and Prevention (CDC), around 5-10% of mothers suffer from postpartum depression within two weeks after childbirth.
As per a research study published in NCBI in 2018, approximately 673 thousand suicide attempt cases were reported globally each year between 2000.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high disposable income, and availability of effective treatment methods. Moreover, increasing awareness about mental health is positively influencing regional growth. Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising disposable income and improving healthcare infrastructure in emerging countries such as China and India.
Moreover, government initiatives are also being undertaken by various countries within this region with a view toward reducing maternal mortality rate due to complications arising out of postpartum depression or anxiety disorders coupled with stress reactions following childbirth that may lead either directly or indirectly cause these conditions leading risks death (i.e., sepsis).
Growth Factors:
- Increasing awareness about postpartum depression and its treatment options among pregnant women and new mothers.
- Growing number of research studies on postpartum depression that are helping to improve understanding of the condition and identify new treatment approaches.
- increasing number of health care providers who are knowledgeable about and comfortable treating postpartum depression.
- Availability of effective pharmacologic and non-pharmacologic treatments for postpartum depression, including counseling, therapy, and medication management therapies
Scope Of The Report
Report Attributes
Report Details
Report Title
Postpartum Depression Treatment Market Research Report
By Type
Selective Serotonin Reuptake Inhibitors, Serotonin Norepinephrine Reuptake Inhibitors, Other Antidepressants
By Application
Hospitals, Clinics, Other
By Companies
Allergan, Anikem Laboratories, Cipla, Eli Lilly, Intas Pharmaceutical, Marinus Pharmaceuticals, Mylan, Pfizer, SAGE Therapeutics, Sun Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Postpartum Depression Treatment Market Report Segments:
The global Postpartum Depression Treatment market is segmented on the basis of:
Types
Selective Serotonin Reuptake Inhibitors, Serotonin Norepinephrine Reuptake Inhibitors, Other Antidepressants
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Anikem Laboratories
- Cipla
- Eli Lilly
- Intas Pharmaceutical
- Marinus Pharmaceuticals
- Mylan
- Pfizer
- SAGE Therapeutics
- Sun Pharmaceuticals
Highlights of The Postpartum Depression Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Selective Serotonin Reuptake Inhibitors
- Serotonin Norepinephrine Reuptake Inhibitors
- Other Antidepressants
- By Application:
- Hospitals
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Postpartum Depression Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Postpartum depression treatment is a combination of medication and therapy. Medication can help to relieve symptoms, while therapy can help to improve the woman's mood and outlook.
Some of the major companies in the postpartum depression treatment market are Allergan, Anikem Laboratories, Cipla, Eli Lilly, Intas Pharmaceutical, Marinus Pharmaceuticals, Mylan, Pfizer, SAGE Therapeutics, Sun Pharmaceuticals.
The postpartum depression treatment market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Postpartum Depression Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Postpartum Depression Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Postpartum Depression Treatment Market - Supply Chain
4.5. Global Postpartum Depression Treatment Market Forecast
4.5.1. Postpartum Depression Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Postpartum Depression Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Postpartum Depression Treatment Market Absolute $ Opportunity
5. Global Postpartum Depression Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Postpartum Depression Treatment Market Size and Volume Forecast by Type
5.3.1. Selective Serotonin Reuptake Inhibitors
5.3.2. Serotonin Norepinephrine Reuptake Inhibitors
5.3.3. Other Antidepressants
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Postpartum Depression Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Postpartum Depression Treatment Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Postpartum Depression Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Postpartum Depression Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Postpartum Depression Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Postpartum Depression Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Postpartum Depression Treatment Demand Share Forecast, 2019-2026
9. North America Postpartum Depression Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Postpartum Depression Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Postpartum Depression Treatment Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Postpartum Depression Treatment Market Size and Volume Forecast by Type
9.7.1. Selective Serotonin Reuptake Inhibitors
9.7.2. Serotonin Norepinephrine Reuptake Inhibitors
9.7.3. Other Antidepressants
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Postpartum Depression Treatment Demand Share Forecast, 2019-2026
10. Latin America Postpartum Depression Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Postpartum Depression Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Postpartum Depression Treatment Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Postpartum Depression Treatment Market Size and Volume Forecast by Type
10.7.1. Selective Serotonin Reuptake Inhibitors
10.7.2. Serotonin Norepinephrine Reuptake Inhibitors
10.7.3. Other Antidepressants
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Postpartum Depression Treatment Demand Share Forecast, 2019-2026
11. Europe Postpartum Depression Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Postpartum Depression Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Postpartum Depression Treatment Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Postpartum Depression Treatment Market Size and Volume Forecast by Type
11.7.1. Selective Serotonin Reuptake Inhibitors
11.7.2. Serotonin Norepinephrine euptake Inhibitors
11.7.3. Other Antidepressants
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Postpartum Depression Treatment Demand Share, 2019-2026
12. Asia Pacific Postpartum Depression Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Postpartum Depression Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Postpartum Depression Treatment Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Postpartum Depression Treatment Market Size and Volume Forecast by Type
12.7.1. Selective Serotonin Reuptake Inhibitors
12.7.2. Serotonin Norepinephrine Reuptake Inhibitors
12.7.3. Other Antidepressants
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Postpartum Depression Treatment Demand Share, 2019-2026
13. Middle East & Africa Postpartum Depression Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Postpartum Depression Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Postpartum Depression Treatment Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Postpartum Depression Treatment Market Size and Volume Forecast by Type
13.7.1. Selective Serotonin Reuptake Inhibitors
13.7.2. Serotonin Norepinephrine Reuptake Inhibitors
13.7.3. Other Antidepressants
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Postpartum Depression Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Postpartum Depression Treatment Market: Market Share Analysis
14.2. Postpartum Depression Treatment Distributors and Customers
14.3. Postpartum Depression Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Allergan
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Anikem Laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cipla
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Eli Lilly
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Intas Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Marinus Pharmaceuticals
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Mylan
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pfizer
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. SAGE Therapeutics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sun Pharmaceuticals
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
